
Conference Coverage
Latest News

What Pharmacists Should Know About Long COVID and Brain Health

Depression May Be an Early Manifestation of Neurodegenerative Changes Leading to Movement Disorders

Pharmacist Strategies for Navigating Supplement Use in Patients on TNF Inhibitors

Early-Line Immunotherapy Challenges the Role of Transplant in Multiple Myeloma

Circulating Extracellular Vesicles Contribute to Heart Failure Pathogenesis in CKD

Shorts










Podcasts
Videos
Continuing Education
All News

Hospital pharmacies enhance efficiency and reduce waste through innovative medication management and RFID technology, ensuring optimal patient care and safety.

Rocatinlimab shows promise in treating moderate-to-severe atopic dermatitis, offering significant symptom relief.

Explore the evolving landscape of myelofibrosis treatment, focusing on personalized therapy, JAK inhibitors, and the role of pharmacists in patient care.

Ann Marie Navar explains how enlicitide decanoate delivers LDL-C reductions comparable with injectable PCSK9 inhibitors, which could improve access to nonstatin therapy for patients not at goal.

New research reveals weaknesses in the STOPP/START version 3 criteria, highlighting the need for stronger evidence in geriatric medication management.

Technological change and COVID-19–related staffing challenges have intensified the need for pharmacy technician career growth and retention strategies. Mayo Clinic implemented an inclusive 5-tier career ladder with expanded training and compensation, reducing turnover by nearly 50% and improving satisfaction, demonstrating the impact of structured advancement on workforce stability and professional development.

Jordan Harper, DMD, discusses innovative fluoride-free toothpaste tablets with hydroxyapatite, offering effective oral care solutions for all patients.

Insufficient sleep significantly impacts life expectancy, highlighting the need to prioritize quality rest for better health and longevity.

The FDA approves gepotidacin as a groundbreaking oral treatment for uncomplicated urogenital gonorrhea.

A study determined that lifestyle factors and comorbidities were more likely to be associated with the onset of diabetes.

FDA grants Priority Review for gedatolisib, a promising treatment for advanced HR+/HER2- breast cancer, showcasing significant efficacy in recent trials.

Jeffery Goad, PharmD, MPH, outlines how recent changes to the childhood immunization schedule may affect vaccine confidence, uptake, and public health, while highlighting the essential role pharmacists play in patient education.

Pharmacists enhance community health by offering test-and-treat services for COVID-19, influenza, strep, and RSV, improving access to care.

Discover how hydroxyapatite toothpaste tablets revolutionize oral care with eco-friendly, effective, and gentle alternatives to traditional fluoride toothpaste.

Pharmacists enhance health care delivery by managing medication refills, addressing drug shortages, and supporting chronic disease management.

New research reveals circulating tumor cells can predict patient response to tarlatamab in small cell lung cancer, enhancing personalized treatment strategies.

Improving Health Equity Through Pharmacist-Led Care Is a Collective Necessity Requiring a Multifaceted, Collaborative Approach

Recent research reveals no significant link between prenatal acetaminophen use and increased risks of autism or ADHD in children, challenging FDA claims.

New research reveals PUF60's critical role in triple-negative breast cancer, highlighting RNA splicing as a promising therapeutic target for oncology.

Dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists were found to offer neuroprotective effects to patients who were administered the medications.

Ali Dehghani, DO, highlights that shingles vaccination not only prevents rash but is also associated with lower risks of major cardiovascular events, dementia, and mortality, underscoring pharmacists’ role in patient counseling and preventive care.

Veterinary pharmacy education gaps hinder pharmacists' ability to safely manage animal prescriptions, impacting patient care and public health.

The FDA approved oral semaglutide to reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes (T2D).

























